Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Circle Pharma is a biotechnology company creating bioavailable macrocyclic peptide therapeutics that target protein-protein interactions.
Aktis Oncology is a biotechnology company that designs and develops novel class radiopharmaceuticals.
Sitryx is a biopharmaceutical company develops disease modifying therapeutics in immuno-oncology and immuno-inflammation.
Volastra Therapeutics is a biotechnology company developing novel therapies for the treatment of metastatic cancers.
HAYA Therapeutics is a biotechnology company developing precision RNA-guided medicines that target the dark genome.
Synapse Energy Economics is a consulting firm providing economic and policy analysis for the electric power sector.
Artax Biopharma is a biopharmaceutical company that develops new therapies for autoimmune and inflammatory diseases.
Amber Bio is a biotechnology company pioneering new gene editing modalities using multi-kilobase edits.
Leal Therapeutics develops novel therapeutics for patients.
Alchemab Therapeutics is developing protective antibodies designed to keep people free of hard-to-treat diseases.
Ratio Therapeutics is a clinical-phase pharmaceutical company that develops radiopharmaceuticals for solid tumors.
DELFI's AI platform uses whole-genome sequencing to detect cancer-associated cfDNA fragmentation patterns in the blood.
Auron aims to cure cancer therapeutics from cell killing to transformation of malignant cells into more normal functioning cells.
AdvanCell develops targeted alpha radiopharmaceutical therapies for cancer and supports their development and manufacturing.
Oura designs and develops wearable rings that track sleep and performance metrics for health and wellness monitoring.
Alto Neuroscience is a clinical-stage biopharmaceutical company that creates precision medicines through its AI-driven biomarker platform.
Mozart is a biotech startup focusing on the development of disease-modifying therapies for autoimmune and inflammatory diseases.
Signify Bio is a biotechnology company harnessing the human body for the production of in situ protein therapeutics.
ProQR Therapeutics is a biotech company focused on developments of drugs to treat genetic disorders.
Lycia Therapeutics is a biotechnology company that focuses on developing technology that utilizes lysosome-targeting chimeras.
Absci is the drug & target discovery company harnessing deep learning AI & synthetic biology to expand the therapeutic potential of proteins
TRIMTECH Therapeutics treats inflammatory and persistent CNS conditions by focusing on the elimination of harmful proteins.
AltPep provides a novel approach for tackling amyloid diseases, with diagnostic, therapeutic and anti-biofilm applications.
Laverock Therapeutics is a biotechnology company developing programmable gene control technologies for advanced cell and gene therapies.
Eli Lilly has invested in 163 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Eli Lilly's top investment sectors include Biotechnology, Health Care, Therapeutics, Medical, Life Science. The firm invests across 18 different industry categories.
Among tracked funding rounds, Oura received $900.0M in a Corporate Round round. Eli Lilly's total known invested capital is $12.0B.
Eli Lilly's average investment size is $90.8M across its portfolio of 163 companies.
Recent Eli Lilly portfolio additions include Circle Pharma, Aktis Oncology, Sitryx Therapeutics, Volastra Therapeutics, HAYA Therapeutics. These companies were founded in 2020 or later.